• Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

Lockheed Martin (LMT)

National defense is detached from the economic cycle. The government can afford to cut the defense budget during peacetime, but not during an active war. Russia’s invasion of Ukraine and rising tensions in the Taiwan Strait have compelled the U.S. congress to expand the defense budget this year.

This expansion is a windfall for arms suppliers like Lockheed Martin. The stock has outperformed both the S&P 500 and Nasdaq this year. It’s up 23% year to date. Despite that surge, the stock trades at just 25 times earnings per share.

During the 2008 crisis, Lockheed Martin lost half its value. But that was because the government cut its defense budget. This year, they’re likely to do the opposite.

The Department of Defense is expected to keep investing in military and aerospace technology despite inflation and economic headwinds, according to consulting firm McKinsey.

That makes Lockheed Martin relatively recession-proof.

Find a financial adviser in minutes

Are you confident in your retirement savings? Get advice on your investment portfolio from a certified professional through WiserAdvisor. It only takes 5 minutes to connect with an adviser who puts you first.

Get Started

Dollar General (DG)

Essential businesses that compete on price are also recession-resistant. Dollar General is a perfect example. It should see more foot traffic as families pivot to discount retailers to deal with rising inflation.

Dollar General wasn’t publicly-traded during the 2008 crisis, but its rival Dollar Tree was. The stock was pretty much flat between 2007 and 2009 with a temporary dip in between. Dollar General could have a similar, stable experience.

In the first quarter of 2022, Dollar General saw a 4% surge in net sales. In fact, the company raised its guidance for the second half of the year. Management expects sales to grow 10.5% to 15% this year. Diluted earnings per share are also expected to expand 12% to 14%.

The stock is up nearly 7%year to date and trades at a modest valuation of 26 times earnings per share.

Clorox (CLX)

Clorox is another recession-resistant essential business. Consumers don’t cut back on disinfectant wipes and bleach regardless of economic conditions — particularly right after a major global pandemic.

Clorox delivered 24% earnings growth and 35% dividend growth during the Great Financial Crisis. In fact, it has increased dividends every year for 45 years. It’s unlikely to disappoint this year. The company’s net sales jumped 2% in the most recent quarter.

The stock is down 17% year-to-date, but it could have less downside than the rest of the market given its recession-resistant business model.

Sponsored

Follow These Steps if you Want to Retire Early

Secure your financial future with a tailored plan to maximize investments, navigate taxes, and retire comfortably.

Zoe Financial is an online platform that can match you with a network of vetted fiduciary advisors who are evaluated based on their credentials, education, experience, and pricing. The best part? - there is no fee to find an advisor.

About the Author

Vishesh Raisinghani

Vishesh Raisinghani

Freelance Writer

Vishesh Raisinghani is a freelance contributor at MoneyWise. He has been writing about financial markets and economics since 2014 - having covered family offices, private equity, real estate, cryptocurrencies, and tech stocks over that period. His work has appeared in Seeking Alpha, Motley Fool Canada, Motley Fool UK, Mergers & Acquisitions, National Post, Financial Post, and Yahoo Canada.

What to Read Next

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter.